Clinical trials - Press Releases

Date	Title	Company
15-Sep-2020	AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103	Amryt
15-Sep-2020	Live Event: Recent Austrian Corona Measures Validate New euroPLX Concept	RauCon
15-Sep-2020	Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates	Onyx Health
15-Sep-2020	SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS	Shionogi & Co., Ltd
15-Sep-2020	Royal Society of Chemistry’s journal archives now available to companies for Text and Data Mining	The Royal Society of Chemistry
15-Sep-2020	Novartis reports positive topline results from the first Phase III trial of Beovu® versus aflibercept in patients with diabetic macular edema (DME)	Novartis
15-Sep-2020	ISCT issues key findings and recommendations following 2020 Annual Meeting for cell and gene therapy industry	The International Society for Cell & Gene Therapy (ISCT)
15-Sep-2020	Neuraxpharm acquires market-leading value-added product for emergency treatment of epileptic children	Neuraxpharm
15-Sep-2020	Time for the adaptive profession – APM reveals findings of its Projecting the Future report	Association for Project Management (APM)
15-Sep-2020	The Net Zero Health Service	Ricardo
15-Sep-2020	Kiadis announces U.S. FDA approval of the Abigail Wexner Research Institute at Nationwide Children’s Hospital’s IND for a COVID-19 clinical trial with off-the-shelf K-NK cells using Kiadis’ proprietary platforms	Kiadis Pharma N.V.
15-Sep-2020	FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis	Regeneron
15-Sep-2020	Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week, Allowing Faster Patient Management Decisions	Biocartis Group NV
15-Sep-2020	Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalised Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial	Eli Lilly and Company
14-Sep-2020	New real-world data for ONGENTYS®▼ (opicapone) released at the International Congress of Parkinson's Disease and Movement Disorders (MDS)	Bial
10-Sep-2020	ReNeuron Group plc - AGM Trading Update	ReNeuron Group plc
10-Sep-2020	Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis	Thermo Fisher Scientific
10-Sep-2020	Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion	Merck
10-Sep-2020	HealthTech Innovation Days Announce Details of Conference Program & Attendees	HealthTech
10-Sep-2020	ECCRT and IDDI establish partnership for continuous development of IDDI global team members	International Drug Development Institute (IDDI)